<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">148</article-id><article-id pub-id-type="doi">10.15690/vramn.v68i9.778</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT MESSAGES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">PLATELET ACTIVITY IN THE CHRONIC SCHIZOPHRENIC PATIENTS DURING ATTACKS OUTCOME AND REMISSION DEVELOPMENT</article-title><trans-title-group xml:lang="ru"><trans-title>АКТИВАЦИЯ ТРОМБОЦИТОВ У МУЖЧИН, ХРОНИЧЕСКИ БОЛЬНЫХ ШИЗОФРЕНИЕЙ, В ПРОЦЕССЕ ВЫХОДА ИЗ ПРИСТУПА И ФОРМИРОВАНИЯ РЕМИССИИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Brusov</surname><given-names>O. S.</given-names></name><name xml:lang="ru"><surname>Брусов</surname><given-names>О. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, chief of the clinical biochemistry laboratory of the Federal State Budgetary Institution «Mental Health Research Center» of RAMS. Address: bld. 16, build. 3, 2, Zagorodnoye Route, Moscow, 117152; tel.: (495) 952-91-41</p></bio><email>oleg_brusov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zlobina</surname><given-names>G. P.</given-names></name><name xml:lang="ru"><surname>Злобина</surname><given-names>Г. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, senior research scientist of the clinical biochemistry laboratory of the Federal State Budgetary Institution «Mental Health Research Center» of RAMS. Address: bld. 16, build. 3, 2, Zagorodnoye Route, Moscow, 117152; tel.: (495) 952-91-41</p></bio><email>zlobina2000@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Mental Health Research Center of the Russian Academy of Medical Sciences, Moscow, Russian Federation</institution></aff><aff><institution xml:lang="ru">Научный центр психического здоровья РАМН, Москва, Российская Федерация</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-09-10" publication-format="electronic"><day>10</day><month>09</month><year>2013</year></pub-date><volume>68</volume><issue>9</issue><issue-title xml:lang="en">Vestnik Rossiiskoi akademii medetsinskikh nauk / Annals of the Russian academy of medical sciences</issue-title><issue-title xml:lang="ru">Вестник Российской академии медицинских наук</issue-title><fpage>42</fpage><lpage>45</lpage><history><date date-type="received" iso-8601-date="2015-08-07"><day>07</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1970, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1970, Издательство "Педиатръ"</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/148">https://vestnikramn.spr-journal.ru/jour/article/view/148</self-uri><abstract xml:lang="en"><p><italic>The purpose of this work was to evaluate the degree of activation of platelets chronically schizophrenic patients with paroxysmal course of the disease during outcome from the attack of disease or in process of forming of the remission. Platelets in platelet-rich-plasma (PRP) and after PRP gel-filtration through the column with Sepharose CL-2B taken from the ulnar vein of males with chronic schizophrenia during outcome from the attack of disease or in process of forming of the remission were measured. </italic><italic>Patients were investigated on the peak of the disease attack (visit 1), at the stage of significant improvement of clinical state (visit 2), and at the stage of stable drug-induced remission (visit 3). Platelet quantities in PRP prepared by centrifugation are equal in patients in visits 1, 2 or 3. </italic><italic>These platelets quantities are much less than similar platelet quantities in healthy individuals matched in age. The additional decreases of platelet quantities were found after the elution of PRP platelets from the column with Sepharose CL-2B. </italic><italic>These additional platelet quantity losses are increased from visit 1 to visit 3.</italic><italic> </italic><italic>Such losses of cells indicate decrease in their resistance to various influences, their activation in spite of remission development in this group of patients.</italic><italic/></p><p> </p></abstract><trans-abstract xml:lang="ru"><p><italic>Цель настоящей работы - оценка степени активации тромбоцитов хронически больных шизофренией с приступообразным течением болезни в процессе выхода из приступа и формирования ремиссии. Оценивали число тромбоцитов в обогащенной тромбоцитами плазме (ОТП) и в элюате после гель-фильтрации ОТП через колонку с сефарозой CL-2B у мужчин, хронически больных шизофренией, в процессе выхода из приступа и формирования ремиссии. Больные были обследованы на высоте приступа (визит 1), на этапе значительного улучшения состояния (визит 2) и на этапе сформированной лекарственной терапии (визит 3). В ОТП, полученной центрифугированием, число тромбоцитов было одинаковым у больных при 1-м, 2-м, 3-м визите и при этом значительно меньше, чем у здоровых доноров. Хроматография тромбоцитов с использованием сефарозы CL-2B продемонстрировала дополнительные потери тромбоцитов больных, при этом потери тромбоцитов возрастали от 1-го к 3-му визиту. Такие потери клеток указывают на снижение их резистентности к различным воздействиям, их активацию, несмотря на формирование ремиссии у больных.<bold/></italic></p><p> </p></trans-abstract><kwd-group xml:lang="en"><kwd>platelets</kwd><kwd>schizophrenia</kwd><kwd>remission</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>тромбоциты</kwd><kwd>шизофрения</kwd><kwd>ремиссия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Yamamoto H., Gurney M.E. Human platelets contain brain-derived neurotrophic factor. J. Neurosci. 1990; 10 (11): 3469–78.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Yeaman M.R., Tang Y.Q., Shen A.J. et al. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect. Immun. 1997; 65 (3): 1023–1031.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Zarbock A., Polanowska-Grabowska R.K., Ley K.. Platelet-neutrophil-interactions:linking hemostasis and inflammation. Blood Rev. 2007; 2 (3): 99–111.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Klinger M.H., Jelkmann W. Role of blood platelets in infection and inflammation. J. Interferon Cytokine Res. 2002; 22 (9): 913–922.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Strous R.D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system degradation: A comprehensive model updated and revisited. J. Autoimm. 2006; 27 (2): 71–80.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Yeaman M.R., Bauer A.S. Antimicrobial peptides from platelets. Drug Resist. Updates. 1999; 2 (2): 116–126.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 2002; 110 (3): 249–257.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Shcherbakova I.V., Kaleda V.G.,Barkhatova A.N., Klyushnik T. P. Markers of endothelial dysfunction in attack-like progressive schizophrenia. Zhurnal nevrologii i psikhiatrii = Journal of Neurology and Psychiatry. 2005; 105(3): 43–46.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Belsham B. Glutamate and its role in psychiatric illness. Hum. Psychopharmacol. 2001; 16 (2): 139–146.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Zlobina G.P., Brusov O.S., Morozova M.A., Beniashvili A.G. Properties and state of separation of platelets in schizophrenic patients. Zhurnal nevrologii i psikhiatrii = Journal of Neurology and Psychiatry. 2009; 109(10): 47–50.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Leucht S., Beitinger R., Kissling W. On the concept of remission in schizophrenia. Psychopharmacol. 2007; 194 (4): 453–461.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Rossi A., Bagala A., Del Curatolo V., Scapati F., Bemareggi M.M., Giustra M.G. Remission in schizophrenia: one-year italian prospective study of risperidone long-acting injectable (RLA) in patients with schizophrenia or schizoaffective disorder. Hum. Psychopharmacol. 2009; 24 (7): 574–583.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Kiktenko A.I., Zlobina G.P.,Shchurin M.R., Kleshchinov V.N. Influence of different methods of isolation of platelets on the surface structure and biochemical parameters serotonin sistmy these cells. Byulleten' eksperimental'noi biologii = Bulletin of Experimental Biology. 1991; 112(11): 485–488.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Shitikova А.S. Trombotsitarnyy gemostaz. [Thrombocytic Hemostasis]. Saint-Petersburg, SPbGMU, 2000. 227 p.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Uzbekov M.G., Smolina N.V., Misionzhnik E.Yu., Molodetskikh A.V., Dobretsov G.E., Grizunov Yu.A. Zhurnal nevrologii i psikhiatrii = Journal of Neurology and Psychiatry. 2008; 108(5): 67–70.</mixed-citation></ref></ref-list></back></article>
